US 8658616
Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virus
granted A61PA61P31/00A61P31/12
Quick answer
US patent 8658616 (Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virus) held by University College Cardiff Consultants Limited expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- University College Cardiff Consultants Limited
- Grant date
- Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P31/00, A61P31/12, A61P31/14